Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 19, 2013 08:00 ET | Source: Topo Athletic

Topo Athletic Laces Up for Speed and Rugged Trails

NEWTON, MA--(Marketwired - Nov 19, 2013) - Innovative footwear brand Topo Athletic announced today the addition of two new models to its expanding shoe portfolio: the Speed Trainer (ST) and Mountain...
November 19, 2013 08:00 ET | Source: Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Amarin Corporation, plc of Class Action Lawsuit and Upcoming Deadline -- AMRN

NEW YORK, Nov. 19, 2013 (GLOBE NEWSWIRE) -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP has filed a class action lawsuit against Amarin Corporation, plc ("Amarin" or the "Company")...
November 19, 2013 08:00 ET | Source: Towerstream

Towerstream to Present at Sixth Annual LD Micro Conference

MIDDLETOWN, R.I., Nov. 19, 2013 (GLOBE NEWSWIRE) -- Towerstream Corporation (Nasdaq:TWER), a leading 4G and Small Cell Rooftop Tower company, announced that its President and Chief Executive Officer,...
November 19, 2013 08:00 ET | Source: PwC

Globally, Tax Rate Policies Vary as Economies Continue to Reform Tax Compliance Systems

MOSCOW, Nov. 19, 2013 (GLOBE NEWSWIRE) -- Economies around the world are adopting a range of policies as they strive to strike a balance between raising tax revenues and encouraging growth, according...
November 19, 2013 08:00 ET | Source: Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Vical Incorporated of Class Action Lawsuit and Upcoming Deadline -- VICL

NEW YORK, Nov. 19, 2013 (GLOBE NEWSWIRE) -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP has filed a class action lawsuit against Vical Incorporated ("Vical" or the "Company") (Nasdaq:VICL)...
November 19, 2013 08:00 ET | Source: Stemline Therapeutics, Inc.

Stemline Therapeutics Announces Clinical Trial Results With SL-701, a Phase 2 Therapeutic for High-Grade Glioma, in an Additional Indication: Data to be Presented at the Society of Neuro-Oncology (SNO) Annual Meeting

NEW YORK, Nov. 19, 2013 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that clinical trial results of SL-701, a Phase 2 therapeutic entering registration-directed...
November 19, 2013 08:00 ET | Source: ClearPoint Neuro, Inc.

MRI Interventions' ClearPoint System Facilitates Asleep DBS Surgery at San Francisco VA Medical Center for Veterans With Parkinson's Disease

IRVINE, Calif., Nov. 19, 2013 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that Veterans Affairs Medical Center (VAMC) in San Francisco, California, has become the first VA...
November 19, 2013 08:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Sponsors Chronic Fatigue Syndrome Conference at Mount Sinai Medical Center in New York

PHILADELPHIA, Nov. 19, 2013 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) announced its sponsorship of the Conference on "Diagnosis, Treatments and New Developments in ME and CFS" ("Myalgic...
November 19, 2013 08:00 ET | Source: WhoKnows

WhoKnows Raises Series A Round Funding Led by PivotNorth Capital and Joins Citrix Startup Accelerator to Introduce Its Knowledge Acceleration Platform

MOUNTAIN VIEW, Calif., Nov. 19, 2013 (GLOBE NEWSWIRE) -- WhoKnows today announced it raised Series A financing from PivotNorth Capital, the Citrix Startup Accelerator and angel investors for its...
November 19, 2013 08:00 ET | Source: Melinta Therapeutics

Melinta Therapeutics Prepares for Late-Stage Product Launches with Appointment of Sue Cammarata, M.D. as Chief Medical Officer

NEW HAVEN, Conn, Nov. 19, 2013 (GLOBE NEWSWIRE) -- Melinta Therapeutics today announced the appointment of Sue Cammarata, M.D. as chief medical officer. In this role, Dr. Cammarata will be...

1 ...232003 232004 232005 ...316529